
Picket Pharmaceuticals is a company that uses a proprietary AI data tool to identify undervalued essential medicines at risk of shortage. They manufacture and commercialize these products proactively to prevent shortages, aiming to improve patient care by reducing delays, medication errors, and lack of access to life-saving drugs. Their business model focuses on stabilizing markets and reducing prices for generic drugs in the US, with a goal to reduce generic drug shortages by 10% over the next five years. They have identified hundreds of at-risk, high-value pharmaceutical assets to bring to market, positioning themselves as a key player in addressing drug shortages through data-driven manufacturing and commercialization.

Picket Pharmaceuticals is a company that uses a proprietary AI data tool to identify undervalued essential medicines at risk of shortage. They manufacture and commercialize these products proactively to prevent shortages, aiming to improve patient care by reducing delays, medication errors, and lack of access to life-saving drugs. Their business model focuses on stabilizing markets and reducing prices for generic drugs in the US, with a goal to reduce generic drug shortages by 10% over the next five years. They have identified hundreds of at-risk, high-value pharmaceutical assets to bring to market, positioning themselves as a key player in addressing drug shortages through data-driven manufacturing and commercialization.
Business: Develops and commercializes complex generic pharmaceuticals to prevent drug shortages
Founded: 2018
Headquarters: New York, New York
Founder & CEO: Joshua Kriger
Employees: 1–10
Known investor: E Squared Capital Management
Drug shortages and unstable generic pharmaceutical markets in the US
2018
Biotechnology
Seed-stage investor listed; no public round amount available in provided evidence
“E Squared Capital Management”